Procurement Summary
Country : Serbia
Summary : Medicines Outside the List of Medicines
Deadline : 29 Mar 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 98746653
Document Ref. No. : A165/2024
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Purchaser : UNIVERSITY CLINICAL CENTER OF SERBIA
RS110 - Belgrade region, BELGRADE
Serbia
Email :dean.firkelj@gmail.com
Tender Details
Ceftolozan/tazobactam, Dantrolene, Epinephrine, Evolocumab, Faricimab, Fluorescein sodium, Hypotonic sodium chloride solution, Human fibrinogen, Human hemin, Indocyanine green, Anti-human Tlymphocyte immunoglobulin (horse), Cabozatinib, Human coagulation factor XIII concentrate, Lorazepam, Octenidine, phenoxyethanol, oseltamivir, papaverine hydrochloride, pegfilgrastim, peginterferon alfa-2a, polatuzumab vedotin
Status of the procedure :- Ordering party UNIVERSITY CLINICAL CENTER OF SERBIA Ordering place RS110 - Belgrade region, BELGRADEName of procurement Medicines outside the list of medicines Reference number A165/2024 Type of itemGood Estimated value Type of procedure Open procedureDeadline for submission 29.03.2024 08:00:00 Status of the procedure Published
Deadline for submission : 29.03.2024 08:00:00
Documents
Tender Notice